PHOTOCURE ASA financials
PHOTOCURE ASA
5967007LIEEXZXG8OW35 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | NOK 525.4M | NOK 500.7M |
| Cost of sales | NOK 30.7M | NOK 26.1M |
| Gross profit | NOK 494.7M | NOK 474.5M |
| Other income | NOK 0 | NOK 0 |
| Operating profit (EBIT) | NOK 20.4M | NOK 27.8M |
| Net finance income / (cost) | -NOK 12.0M | -NOK 18.1M |
| Finance costs | NOK 36.9M | NOK 41.2M |
| Profit before tax | NOK 8.4M | NOK 9.7M |
| Income tax expense | NOK 11.7M | NOK 8.8M |
| Profit for the year | -NOK 3.3M | NOK 979.0K |
| Total comprehensive income | NOK 1.9M | -NOK 42.0K |
| Per share | ||
| Basic EPS | NOK -0.12 | NOK 0.04 |
| Diluted EPS | NOK -0.12 | NOK 0.04 |
| Free cash flow / share | NOK 2.35 | NOK 1.47 |
| Cash flow statement | ||
| Net cash from operating activities | NOK 76.8M | NOK 48.3M |
| Income taxes paid | NOK 1.3M | NOK 3.1M |
| Net cash from investing activities | NOK 1.4M | -NOK 594.0K |
| Purchase of PP&E (capex) | NOK 11.4M | NOK 12.3M |
| Net cash from financing activities | -NOK 43.8M | -NOK 56.3M |
| Repayments of borrowings | NOK 0 | NOK 12.5M |
| Lease liability payments | NOK 5.9M | NOK 8.5M |
| Balance sheet | ||
| Total assets | NOK 739.1M | NOK 712.0M |
| Non-current assets | NOK 315.1M | NOK 339.5M |
| Property, plant & equipment | NOK 36.2M | NOK 33.5M |
| Intangible assets & goodwill | NOK 144.0M | NOK 144.0M |
| Current assets | NOK 424.0M | NOK 372.4M |
| Inventories | NOK 39.5M | NOK 37.2M |
| Trade & other receivables | NOK 66.9M | NOK 59.7M |
| Cash & equivalents | NOK 293.9M | NOK 259.5M |
| Total equity | NOK 501.7M | NOK 482.8M |
| Non-current liabilities | NOK 133.5M | NOK 146.0M |
| Lease liabilities (non-current) | NOK 10.7M | NOK 14.0M |
| Current liabilities | NOK 103.9M | NOK 83.1M |
| Current portion of long-term borrowings | NOK 15.8M | NOK 14.0M |
| Derived metrics | ||
| Free cash flow | NOK 65.3M | NOK 36.0M |
| Operating margin | 3.9% | 5.6% |
| Net margin | -0.6% | 0.2% |
| Return on equity | -0.7% | 0.2% |
| Cash conversion ratio | -22.98× | 49.35× |
| Capex coverage | 6.71× | 3.93× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -NOK 2.3M | -NOK 10.7M |
| Adjustments For Decrease Increase In Trade and Other Receivables | -NOK 14.9M | -NOK 12.1M |
| Adjustments For Depreciation and Amortisation Expense | NOK 28.8M | NOK 27.7M |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | NOK 1.4M | NOK 1.1M |
| Adjustments For Increase Decrease In Trade and Other Payables | -NOK 218.0K | -NOK 1.6M |
| Adjustments For Interest Expense | NOK 28.1M | NOK 26.3M |
| Adjustments For Interest Income | NOK 12.9M | NOK 11.7M |
| Adjustments For Sharebased Payments | NOK 17.0M | NOK 20.2M |
| Cash Advances and Loans Made To Related Parties | NOK 0 | NOK 0 |
| Current Payables On Social Security and Taxes Other Than Income Tax | NOK 2.6M | NOK 1.2M |
| Deferred Tax Assets | NOK 39.1M | NOK 49.5M |
| Equity and Liabilities | NOK 739.1M | NOK 712.0M |
| Finance Income | NOK 24.9M | NOK 24.6M |
| Increase Decrease In Cash and Cash Equivalents | NOK 34.4M | -NOK 8.6M |
| Increase Decrease Through Exercise of Options | NOK 17.0M | NOK 20.2M |
| Increase Decrease Through Transactions With Owners | NOK 17.0M | NOK 20.2M |
| Interest Paid Classified As Financing Activities | NOK 742.0K | NOK 912.0K |
| Interest Received Classified As Investing Activities | NOK 12.9M | NOK 11.7M |
| Investments In Subsidiaries | NOK 0 | NOK 0 |
| Issue of Equity | NOK 0 | NOK 0 |
| Issued Capital | NOK 13.6M | NOK 13.6M |
| Liabilities | NOK 237.4M | NOK 229.1M |
| Noncurrent Receivables Due From Related Parties | NOK 0 | NOK 0 |
| Noncurrent Recognised Liabilities Defined Benefit Plan | NOK 5.7M | NOK 4.3M |
| Other Adjustments To Reconcile Profit Loss | NOK 4.4M | -NOK 738.0K |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | NOK 5.2M | -NOK 1.0M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | NOK 5.2M | -NOK 1.0M |
| Other Current Liabilities | NOK 66.0M | NOK 48.2M |
| Other Current Receivables | NOK 23.7M | NOK 16.0M |
| Other Expense By Function | NOK 99.5M | NOK 97.1M |
| Other Operating Income Expense | -NOK 474.3M | -NOK 446.7M |
| Purchase of Treasury Shares | NOK 0 | NOK 0 |
| Research and Development Expense | NOK 3.6M | NOK 2.1M |
| Revenue From Contracts With Customers | NOK 491.7M | NOK 446.2M |
| Sale Or Issue of Treasury Shares | NOK 0 | NOK 0 |
| Sales and Marketing Expense | NOK 354.9M | NOK 334.9M |
| Trade and Other Current Payables To Trade Suppliers | NOK 19.4M | NOK 19.7M |
Every line item above is a fact tagged in PHOTOCURE ASA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (NOK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.